A research team at University of Florida Health has been approved for a $15.48 million research funding award by the Patient-Centered Outcomes Research Institute, or PCORI, to study the effectiveness of three medications used to treat hepatitis C. The five-year, randomized clinical trial will be led at UF…
Last week, the Division of Gastroenterology, Hepatology, and Nutrition’s Dr. David Nelson spoke with WCJB-TV20’s Chris Gilmore about recent treatment advances and screening recommendations for Hepatitis C. “This year has seen a real transformation in opportunities,” Dr. Nelson explains, “It use to be we would give people injections of chemotherapy…
Research demonstrating dramatic improvements in treatment options for the more than 3 million people in the United States living with hepatitis C was recognized today, April 10, as one of the Clinical Research Forum’s Top 10 Clinical Research Achievements of 2013. The Clinical Research Forum presented the award to…
Congratulations, Jim!…
Dr. James E. McGuigan was recently recognized during the 6th UF Annual GI/Liver Meeting for more than 40 years of service. He has been an outstanding leader, researcher and physician for the University of Florida Department of Medicine.
Shands at UF in Gainesville was recognized as one of the nationally ranked institutions in Gastroenterology by the most recent U.S. News & World Report Ranking (2012-13)…
Hepatologists at the University of Florida have begun a new clinical trial in search of a better way to treat patients who have advanced, inoperable primary liver cancer but have trouble tolerating standard doses of the only drug available to help them. Funded through a $650,000 grant from Bayer…
